Bausch & Lomb
Eye care and pharmaceutical products manufacturer
Bausch & Lomb has three product lines: Vision Care, Surgical, and Pharmaceuticals. Acquired by Valeant for US$8.7b in 2013.
|Bausch & Lomb Inc||USA||website|
| Bausch Health Companies Inc
owns 100% of Bausch & Lomb Inc
|Bausch & Lomb Inc|
This company appears on PETA's (People for the Ethical Treatment of Animals, USA) 'Companies That Do Test On Animals' list, signifying that they manufacture products that are tested on animals at some stage of development.
Source: PETA (2020)
The California Transparency in Supply Chains Act of 2010 (SB 657) requires companies operating in California to disclose their efforts to eradicate slavery and human trafficking from their direct supply chains. KnowTheChain.org has examined this company's disclosure statement and concluded that it addresses the majority of SB 657 requirements. Follow the link to see this company's disclosure statement.
Source: company website (2013)
|Bausch Health Companies Inc|
This company received an S&P Global ESG Score of 10/100 in the Pharmaceuticals category of the 2019 SAM Corporate Sustainability Assessment, an annual evaluation of companies' sustainability practices. The rankings are based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
Source: S&P Global (2019)
In 2019, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to reduce greenhouse gas emissions and mitigate climate change risk. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Climate Change Score of D.
Source: CDP (2019)
In 2017 this company agreed to pay $US96.25 million to settle an insider-trading suit over their attempt to buy the pharmaceutical firm and Botox maker Allergan in 2014.
Source: news article (2017)
The Bausch Foundation was established in 2017 to improve the lives of patients globally by providing access to safe, effective medicines and by financially supporting health care education and causes around the world. The Foundation supports initiatives aimed at disease prevention, improving patient outcomes and lives, and education related to our core businesses. Additionally, it supports disaster recovery efforts and the underserved in the communities in which we live and work.
Source: company website (2020)
California, the UK and Australia have all enacted legislation requiring companies operating within their borders to disclose their efforts to eradicate modern slavery from their operations and supply chains. Follow the link to see this company's disclosure statement.
Source: Modern Slavery Registry (2018)
This company received a score of 58.1/100 in the Newsweek Green Rankings 2016, which ranks the world's largest publicly traded companies on eight indicators covering energy, greenhouse gases, water, waste, fines and penalties, linking executive pay to sustainability targets, board-level committee oversight of environmental issues and third-party audits. Ranking methodology by Corporate Knights and HIP Investor.
Source: Newsweek (2016)
|Revenue||US$1.38 billion in 2013|
|Employees||11,000 in 2013|
|Subsidiaries||Bausch & Lomb Australia Pty Ltd|
|Address||Rochester, New York, USA|